China Pharma Holdings, Inc.
General ticker "CPHI" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $2.1M (TTM average)
China Pharma Holdings, Inc. does not follow the US Stock Market performance with the rate: -2.0%.
Estimated limits based on current volatility of 6.0%: low 0.54$, high 0.61$
Factors to consider:
- Total employees count: 221 (-4.3%) as of 2025
- Top business risk factors: Market acceptance, Regulatory and compliance, Market competition, R&D failure, Labor/talent shortage/retention
- Current price 32.1% below estimated low
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.83$, 2.08$]
- 2026-12-31 to 2027-12-31 estimated range: [0.64$, 1.69$]
Financial Metrics affecting the CPHI estimates:
- Positive: with PPE of -1.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 1.94 < Operating cash flow per share per price, % of 2.66
- Negative: negative Industry operating income (median)
- Positive: -9.77 < Return on assets ratio (scaled to [-100,100]) of -9.32
- Positive: Inventory ratio change, % of -5.23 <= -3.92
- Positive: Interest expense per share per price, % of 1.83 <= 2.76
- Negative: Industry operating cash flow per share per price (median), % of -0.61 <= 0.01
Short-term CPHI quotes
Long-term CPHI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $7.01MM | $4.53MM | $4.14MM |
| Operating Expenses | $9.76MM | $9.12MM | $7.38MM |
| Operating Income | $-2.75MM | $-4.59MM | $-3.24MM |
| Non-Operating Income | $-0.33MM | $-0.15MM | $0.05MM |
| Interest Expense | $0.33MM | $0.15MM | $0.10MM |
| R&D Expense | $0.24MM | $0.28MM | $0.28MM |
| Income(Loss) | $-3.08MM | $-4.74MM | $-3.19MM |
| Net Income(Loss)* | $-3.08MM | $-4.74MM | $-3.19MM |
| Stockholders Equity | $7.45MM | $7.75MM | $22.74MM |
| Inventory | $3.73MM | $2.27MM | $1.62MM |
| Assets | $16.47MM | $14.89MM | $31.00MM |
| Operating Cash Flow | $-0.70MM | $-0.41MM | $0.15MM |
| Capital expenditure | $0.01MM | $0.29MM | $0.14MM |
| Investing Cash Flow | $-0.01MM | $-0.29MM | $-0.14MM |
| Financing Cash Flow | $0.07MM | $-0.03MM | $-0.29MM |
| Earnings Per Share** | $-0.29 | $-0.27 | $-0.74 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.